A New Injectable Market


Raju Mantena, president and CEO of Orlando-based Icore, an injectable drug management company, has a strict warning for health plans: "Plans need to prepare themselves to slow the increase in injectable spending rather than trying to stop it, because it's not going to stop," he says.

Related Videos
C diff - "Study Limitations and Relevance"
Related Content
© 2023 MJH Life Sciences

All rights reserved.